Economic evaluation of enzalutamide and androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer in the United Kingdom

Additional Metadata
Keywords	Cost-effectiviness; health technology assessment; enzalutamide; anti-androgens;Prostate cancer; hormone-sensitive; metastatic disease;QoL; utility
Thesis Advisor	Holleman, M.S.
Persistent URL	hdl.handle.net/2105/62477
Series	Master Health Economics, Policy and Law
Organisation	Erasmus School of Health Policy & Management
Citation APA Style AAA Style APA Style Cell Style Chicago Style Harvard Style IEEE Style MLA Style Nature Style Vancouver Style American-Institute-of-Physics Style Council-of-Science-Editors Style BibTex Format Endnote Format RIS Format CSL Format DOIs only Format	Tarrahi, F.Z. (2021, July 12). Economic evaluation of enzalutamide and androgen deprivation therapy in men with metastatic hormone-sensitive prostate cancer in the United Kingdom. Master Health Economics, Policy and Law. Retrieved from http://hdl.handle.net/2105/62477

Publication